ARROWHEAD PHARMACEUTICALS, INC. | License Agreements | Business Contracts

First Amendment to Exclusive License and Co-Funding Agreement by and between Arrowhead Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. dated March 15, 2022 (Filed With SEC on May 10, 2022)

Amendment No. 1 to License Agreement by and between Arrowhead Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc., dated December 18, 2018 (Filed With SEC on November 25, 2019)

Amendment No. 2 to License Agreement by and between Arrowhead Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc., dated February (Filed With SEC on November 25, 2019)

ARROWHEAD PHARMACEUTICALS, INC. (20) | License Agreements (3)